论文信息 - Glyburide vs Insulin for Gestational Diabetes-Reply.

Glyburide vs Insulin for Gestational Diabetes-Reply.

the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr O’Malley reports receiving donated study medications from Pfizer, AstraZeneca, and Novartis; serving as a consultant to and being on the advisory boards of Alkermes, Amygdala, Cerecor, Indivior, Mitsubishi Tanabe, and Opiant; being a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative supported by Alkermes, Amygdala, Arbor Pharmaceuticals, Ethypharm, Lilly, Lundbeck, Otsuka, Pfizer, and Indivior; and serving on a scientific panel for Hazelden Foundation. Dr Jordt reports receiving personal fees and nonfinancial support from Hydra Biosciences and nonfinancial support from GlaxoSmithKline Pharmaceuticals. No other disclosures were reported.

H. Affres | M. Senat | J. Bouyer

[1] L. Barbour,et al. Insulin vs Glyburide for Gestational Diabetes. , 2018, JAMA.

[2] H. Affres,et al. Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial , 2018, JAMA.

[3] D. Camenga,et al. Reasons for Cigarillo Initiation and Cigarillo Manipulation Methods among Adolescents. , 2017, Tobacco regulatory science.

[4] S. Davis,et al. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus , 2016, Expert opinion on drug metabolism & toxicology.

[5] L. Molyneaux,et al. Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment , 2015, Diabetes Care.

[6] G. Koren,et al. Glyburide Transport Across the Human Placenta , 2015, Obstetrics and gynecology.

[7] S. Caritis,et al. A pharmacologic approach to the use of glyburide in pregnancy. , 2013, Obstetrics and gynecology.

[8] C. Cobelli,et al. Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice , 2009, Clinical pharmacology and therapeutics.

[9] L. Barbour,et al. Predictors of Glyburide Failure in the Treatment of Gestational Diabetes , 2006, Obstetrics and gynecology.

[10] L. Groop,et al. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics , 2004, European Journal of Clinical Pharmacology.